Home » Newsletters » BioWorld MedTech

BioWorld MedTech

April 17, 2012

View Archived Issues

Medtronic reports consistent two-year results for Endurant

No aneurysm-related mortality. No conversion to open surgery. No device migration. Read More

Deals roundup: PHL to acquire imaging research portfolio from Bayer Pharma

Report from Europe: Cross-border e-health goes live in Europe

Agreements/contracts: NeuroLogica's BodyTom to integrate Brainlab system

Financings roundup: Molecular Detection closes $1.9M Series B financing

Med-Tech Notes: Iowa Methodist uses a BSD-500

Patent watch: Vermillion receives 15th patent related to OVA1 diagnostic test

Product Briefs

People in the News

MDD's Cardio Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Checkpoint inhibitor journey traces Chinese firms’ path to global revenue
BioWorld
Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...